Request Demo
Recent blog posts
Latest Hotspot
8 min read
NCT07709897 Fosrolapitant Postoperative Nausea and Vomiting Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07709897 clinical trial report covering Fosrolapitant, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07710118 Ceftriaxone Sodium Gonorrhea Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07710118 clinical trial report covering Ceftriaxone Sodium, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07711158 SR-604 Factor VII Deficiency Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07711158 clinical trial report covering SR-604, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07710157 Obinutuzumab Nephrosis, Lipoid Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07710157 clinical trial report covering Obinutuzumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07712094 Cisplatin Gastro-Enteropancreatic Neuroendocrine Tumor Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07712094 clinical trial report covering Cisplatin, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07712029 Pucotenlimab Locally Advanced Malignant Solid Neoplasm Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07712029 clinical trial report covering Pucotenlimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07711418 Rezpegaldesleukin Moderate Atopic Dermatitis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07711418 clinical trial report covering Rezpegaldesleukin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07710196 N-Acetylcysteine amide Usher Syndromes Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07710196 clinical trial report covering N-Acetylcysteine amide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07712692 HPV-16 targeted mRNA vaccine(Novi Technology) Squamous Intraepithelial Lesions of the Cervix Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07712692 clinical trial report covering HPV-16 targeted mRNA vaccine(Novi Technology), Phase 2, endpoints, sponsor, geography, readout timing and developme
Latest Hotspot
8 min read
NCT07710872 Meningococcal vaccine groups A C Y W-135 conjugate (second generation)(Sanofi) Meningococcal Infections Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07710872 clinical trial report covering Meningococcal vaccine groups A C Y W-135 conjugate (second generation)(Sanofi), Phase 3, endpoints, sponsor, geogra
Latest Hotspot
8 min read
NCT07709767 Retlirafusp alfa stomach adenocarcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07709767 clinical trial report covering Retlirafusp alfa, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07710612 ABSK-043 EGFR-mutated non-small Cell Lung Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07710612 clinical trial report covering ABSK-043, Phase 2, endpoints, sponsor, geography, readout timing and development white space.